Galons H - Search Results

1

Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents.

Houzé S, Hoang NT, Lozach O, Le Bras J, Meijer L, Galons H, Demange L. Houzé S, et al. Among authors: galons h. Molecules. 2014 Sep 23;19(9):15237-57. doi: 10.3390/molecules190915237. Molecules. 2014. PMID: 25251193 Free PMC article.

2

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1.

Oumata N, Bettayeb K, Ferandin Y, Demange L, Lopez-Giral A, Goddard ML, Myrianthopoulos V, Mikros E, Flajolet M, Greengard P, Meijer L, Galons H. Oumata N, et al. Among authors: galons h. J Med Chem. 2008 Sep 11;51(17):5229-42. doi: 10.1021/jm800109e. Epub 2008 Aug 13. J Med Chem. 2008. PMID: 18698753

3

Cyclin-dependent kinase inhibitors: a survey of recent patent literature.

Galons H, Oumata N, Meijer L. Galons H, et al. Expert Opin Ther Pat. 2010 Mar;20(3):377-404. doi: 10.1517/13543770903524284. Expert Opin Ther Pat. 2010. PMID: 20180621 Review.

4

Potent inhibitors of CDK5 derived from roscovitine: synthesis, biological evaluation and molecular modelling.

Demange L, Abdellah FN, Lozach O, Ferandin Y, Gresh N, Meijer L, Galons H. Demange L, et al. Among authors: galons h. Bioorg Med Chem Lett. 2013 Jan 1;23(1):125-31. doi: 10.1016/j.bmcl.2012.10.141. Epub 2012 Nov 10. Bioorg Med Chem Lett. 2013. PMID: 23218601

5

CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases.

Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L. Bettayeb K, et al. Among authors: galons h. Oncogene. 2008 Oct 2;27(44):5797-807. doi: 10.1038/onc.2008.191. Epub 2008 Jun 23. Oncogene. 2008. PMID: 18574471

6

CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells.

Delehouzé C, Godl K, Loaëc N, Bruyère C, Desban N, Oumata N, Galons H, Roumeliotis TI, Giannopoulou EG, Grenet J, Twitchell D, Lahti J, Mouchet N, Galibert MD, Garbis SD, Meijer L. Delehouzé C, et al. Among authors: galons h. Oncogene. 2014 Dec 11;33(50):5675-87. doi: 10.1038/onc.2013.513. Epub 2013 Dec 9. Oncogene. 2014. PMID: 24317512 Free PMC article.

7

Roscovitine targets, protein kinases and pyridoxal kinase.

Bach S, Knockaert M, Reinhardt J, Lozach O, Schmitt S, Baratte B, Koken M, Coburn SP, Tang L, Jiang T, Liang DC, Galons H, Dierick JF, Pinna LA, Meggio F, Totzke F, Schächtele C, Lerman AS, Carnero A, Wan Y, Gray N, Meijer L. Bach S, et al. Among authors: galons h. J Biol Chem. 2005 Sep 2;280(35):31208-19. doi: 10.1074/jbc.M500806200. Epub 2005 Jun 23. J Biol Chem. 2005. PMID: 15975926 Free article.

8

Cyclin-dependent kinase inhibitors closer to market launch?

Galons H, Oumata N, Gloulou O, Meijer L. Galons H, et al. Expert Opin Ther Pat. 2013 Aug;23(8):945-63. doi: 10.1517/13543776.2013.789861. Epub 2013 Apr 22. Expert Opin Ther Pat. 2013. PMID: 23600454 Review.

9

Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell lines.

Troadec S, Blairvacq M, Oumata N, Galons H, Meijer L, Berthou C. Troadec S, et al. Among authors: galons h. J Biomed Sci. 2015 Jul 17;22(1):57. doi: 10.1186/s12929-015-0163-x. J Biomed Sci. 2015. PMID: 26184865 Free PMC article.

10

CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.

Bettayeb K, Baunbæk D, Delehouze C, Loaëc N, Hole AJ, Baumli S, Endicott JA, Douc-Rasy S, Bénard J, Oumata N, Galons H, Meijer L. Bettayeb K, et al. Among authors: galons h. Genes Cancer. 2010 Apr;1(4):369-80. doi: 10.1177/1947601910369817. Genes Cancer. 2010. PMID: 21779453 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page